These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
195 related articles for article (PubMed ID: 33491092)
1. IkBζ is a Key Regulator of Tumour Necrosis Factor-a and Interleukin-17A-mediated Induction of Interleukin-36g in Human Keratinocytes. Ovesen SK; Schulze-Osthoff K; Iversen L; Johansen C Acta Derm Venereol; 2021 Feb; 101(2):adv00386. PubMed ID: 33491092 [TBL] [Abstract][Full Text] [Related]
2. IκBζ is a key transcriptional regulator of IL-36-driven psoriasis-related gene expression in keratinocytes. Müller A; Hennig A; Lorscheid S; Grondona P; Schulze-Osthoff K; Hailfinger S; Kramer D Proc Natl Acad Sci U S A; 2018 Oct; 115(40):10088-10093. PubMed ID: 30224457 [TBL] [Abstract][Full Text] [Related]
3. IL-17A synergistically enhances TLR3-mediated IL-36γ production by keratinocytes: A potential role in injury-amplified psoriatic inflammation. Liu S; Wu F; Wu Z; Li Y; Zhang S; Yu N Exp Dermatol; 2019 Mar; 28(3):233-239. PubMed ID: 30614571 [TBL] [Abstract][Full Text] [Related]
4. The human IL-17A/F heterodimer regulates psoriasis-associated genes through IκBζ. Bertelsen T; Iversen L; Johansen C Exp Dermatol; 2018 Sep; 27(9):1048-1052. PubMed ID: 29938836 [TBL] [Abstract][Full Text] [Related]
5. Interleukin (IL)-17/IL-36 axis participates to the crosstalk between endothelial cells and keratinocytes during inflammatory skin responses. Mercurio L; Failla CM; Capriotti L; Scarponi C; Facchiano F; Morelli M; Rossi S; Pagnanelli G; Albanesi C; Cavani A; Madonna S PLoS One; 2020; 15(4):e0222969. PubMed ID: 32352958 [TBL] [Abstract][Full Text] [Related]
6. IκBζ is a key player in the antipsoriatic effects of secukinumab. Bertelsen T; Ljungberg C; Litman T; Huppertz C; Hennze R; Rønholt K; Iversen L; Johansen C J Allergy Clin Immunol; 2020 Jan; 145(1):379-390. PubMed ID: 31622687 [TBL] [Abstract][Full Text] [Related]
7. I-Kappa-B-Zeta Regulates Interleukin-17A/Tumor Necrosis Factor-Alpha Mediated Synergistic Induction of Interleukin-19 and Interleukin-20 in Humane Keratinocytes. Bertelsen T; Iversen L; Johansen C Ann Dermatol; 2021 Apr; 33(2):122-130. PubMed ID: 33935453 [TBL] [Abstract][Full Text] [Related]
9. Characterization of TNF-α- and IL-17A-Mediated Synergistic Induction of DEFB4 Gene Expression in Human Keratinocytes through IκBζ. Johansen C; Bertelsen T; Ljungberg C; Mose M; Iversen L J Invest Dermatol; 2016 Aug; 136(8):1608-1616. PubMed ID: 27117051 [TBL] [Abstract][Full Text] [Related]
10. Synergistic induction of IL-23 by TNFα, IL-17A, and EGF in keratinocytes. Ehst B; Wang Z; Leitenberger J; McClanahan D; De La Torre R; Sawka E; Ortega-Loayza AG; Strunck J; Greiling T; Simpson E; Liu Y Cytokine; 2021 Feb; 138():155357. PubMed ID: 33153894 [TBL] [Abstract][Full Text] [Related]
11. Tacrolimus Inhibits TNF-α/IL-17A-Produced pro-Inflammatory Effect on Human Keratinocytes by Regulating IκBζ. Hu Y; Guo J; Yin L; Tu J; Yin Z Inflammation; 2020 Apr; 43(2):692-700. PubMed ID: 31838663 [TBL] [Abstract][Full Text] [Related]
12. Acitretin inhibits IL-17A-induced IL-36 expression in keratinocytes by down-regulating IκBζ. Tu J; Yin Z; Guo J; He F; Long F; Yin Z Int Immunopharmacol; 2020 Feb; 79():106045. PubMed ID: 31863918 [TBL] [Abstract][Full Text] [Related]
13. IL-36γ sustains a proinflammatory self-amplifying loop with IL-17C in anti-TNF-induced psoriasiform skin lesions of patients with Crohn's disease. Friedrich M; Tillack C; Wollenberg A; Schauber J; Brand S Inflamm Bowel Dis; 2014 Nov; 20(11):1891-901. PubMed ID: 25299544 [TBL] [Abstract][Full Text] [Related]
14. Tumor necrosis factor α-mediated induction of interleukin 17C in human keratinocytes is controlled by nuclear factor κB. Johansen C; Riis JL; Gedebjerg A; Kragballe K; Iversen L J Biol Chem; 2011 Jul; 286(29):25487-94. PubMed ID: 21628458 [TBL] [Abstract][Full Text] [Related]
15. TNFα- and IL-17A-mediated S100A8 expression is regulated by p38 MAPK. Mose M; Kang Z; Raaby L; Iversen L; Johansen C Exp Dermatol; 2013 Jul; 22(7):476-81. PubMed ID: 23800059 [TBL] [Abstract][Full Text] [Related]
17. EGFR ligands synergistically increase IL-17A-induced expression of psoriasis signature genes in human keratinocytes via IκBζ and Bcl3. Dai X; Murakami M; Shiraishi K; Muto J; Tohyama M; Mori H; Utsunomiya R; Sayama K Eur J Immunol; 2022 Jun; 52(6):994-1005. PubMed ID: 35411943 [TBL] [Abstract][Full Text] [Related]
18. miR-378a regulates keratinocyte responsiveness to interleukin-17A in psoriasis. Xia P; Pasquali L; Gao C; Srivastava A; Khera N; Freisenhausen JC; Luo L; Rosén E; van Lierop A; Homey B; Pivarcsi A; Sonkoly E Br J Dermatol; 2022 Aug; 187(2):211-222. PubMed ID: 35257359 [TBL] [Abstract][Full Text] [Related]
19. Khasianine ameliorates psoriasis-like skin inflammation and represses TNF-α/NF-κB axis mediated transactivation of IL-17A and IL-33 in keratinocytes. Yang Y; Zhang Y; Chen X; Su Z; Deng Y; Zhao Q J Ethnopharmacol; 2022 Jun; 292():115124. PubMed ID: 35183690 [TBL] [Abstract][Full Text] [Related]
20. IL-17A plays a central role in the expression of psoriasis signature genes through the induction of IκB-ζ in keratinocytes. Muromoto R; Hirao T; Tawa K; Hirashima K; Kon S; Kitai Y; Matsuda T Int Immunol; 2016 Sep; 28(9):443-52. PubMed ID: 26944069 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]